Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chonzi, David"'
Autor:
Pillai, Manon, Jiang, Yizhou, Lorigan, Paul C, Thistlethwaite, Fiona C, Thomas, Martine, Kirillova, Natalia, Bridgeman, John S, Kueberuwa, Gray, Biswas, Sunetra, Velazquez, Peter, Chonzi, David, Guest, Ryan D, Roberts, Zachary J, Hawkins, Robert E
Publikováno v:
Am J Cancer Res
Nonselected autologous tumor-infiltrating lymphocytes (TILs) may provide advantages over other treatments for solid tumors, including checkpoint inhibitor-refractory melanoma. This retrospective analysis reports a single-center experience of nonselec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aae96403018490da8a7ff004c4aa304e
https://europepmc.org/articles/PMC9441996/
https://europepmc.org/articles/PMC9441996/
Autor:
Sardella, Marco, Belcher, Glyn, Lungu, Calin, Ignoni, Terenzio, Camisa, Manuela, Stenver, Doris Irene, Porcelli, Paolo, D’Antuono, Margherita, Castiglione, Nicola Gian, Adams, Anna, Furlan, Giovanni, Grisoni, Ilaria, Hall, Sarah, Boga, Laura, Mancini, Valentina, Ciuca, Mircea, Chonzi, David, Edwards, Brian, Mangoni, Arduino A, Tuccori, Marco, Prokofyeva, Elena, De Gregorio, Fabio, Bertazzoli Grabinski Broglio, Mario, van Leeuwen, Bert, Kruger, Paola, Rausch, Christian, Le Louet, Hervé
Supplemental material, sj-docx-1-taw-10.1177_20420986211038436 for Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance by Marco Sardella, Glyn Belcher, Calin Lungu, Terenzio Ignoni, Manuela Camisa, Doris Ire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0008395e333e2a78576adfc5744e7ac7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pillai M; Department of Medical Oncology, The Christie, NHS Foundation Trust Manchester, UK., Jiang Y; Instil Bio, Inc. Dallas, TX, USA., Lorigan PC; Department of Medical Oncology, The Christie, NHS Foundation Trust Manchester, UK.; Division of Cancer Sciences, The University of Manchester Manchester, UK., Thistlethwaite FC; Department of Medical Oncology, The Christie, NHS Foundation Trust Manchester, UK.; Division of Cancer Sciences, The University of Manchester Manchester, UK., Thomas M; Instil Bio, Inc. Dallas, TX, USA., Kirillova N; Instil Bio, Inc. Dallas, TX, USA., Bridgeman JS; Instil Bio, Inc. Dallas, TX, USA., Kueberuwa G; Instil Bio, Inc. Dallas, TX, USA., Biswas S; Instil Bio, Inc. Dallas, TX, USA., Velazquez P; Instil Bio, Inc. Dallas, TX, USA., Chonzi D; Instil Bio, Inc. Dallas, TX, USA., Guest RD; Instil Bio, Inc. Dallas, TX, USA., Roberts ZJ; Instil Bio, Inc. Dallas, TX, USA., Hawkins RE; Department of Medical Oncology, The Christie, NHS Foundation Trust Manchester, UK.; Instil Bio, Inc. Dallas, TX, USA.; Division of Cancer Sciences, The University of Manchester Manchester, UK.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2022 Aug 15; Vol. 12 (8), pp. 3967-3984. Date of Electronic Publication: 2022 Aug 15 (Print Publication: 2022).